New Zealand markets open in 20 minutes

FibroGen, Inc. (FGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2200+0.0900 (+7.96%)
At close: 04:00PM EDT
1.2200 0.00 (0.00%)
After hours: 05:29PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
167,493
147,752
140,734
235,309
176,319
Cost of revenue
41,110
18,848
20,280
12,871
8,869
Gross profit
126,383
128,904
120,454
222,438
167,450
Operating expenses
Research development
246,767
282,861
296,791
387,043
252,924
Selling general and administrative
103,797
115,252
124,688
123,925
106,406
Total operating expenses
350,564
398,113
421,479
510,968
359,330
Operating income or loss
-224,181
-269,209
-301,025
-288,530
-191,880
Interest expense
18,156
15,532
1,440
2,153
2,402
Total other income/expenses net
-
-12,606
-
-
-202
Income before tax
-242,929
-286,867
-294,869
-290,683
-188,729
Income tax expense
-38
3
358
347
360
Income from continuing operations
-240,460
-284,232
-293,654
-290,023
-189,291
Net income
-240,460
-284,232
-293,654
-290,023
-189,291
Net income available to common shareholders
-240,460
-284,232
-293,654
-290,023
-189,291
Basic EPS
-3.06
-2.92
-3.14
-3.14
-2.11
Diluted EPS
-3.06
-2.92
-3.14
-3.14
-2.11
Basic average shares
96,185
97,303
93,582
92,349
89,854
Diluted average shares
96,185
97,303
93,582
92,349
89,854